510(k) Report

FDA applicant

Neurometrix, Inc.

Waltham, MA18 decisions1998–20220 recalls

FDA records 18 decisions for Neurometrix, Inc. (Waltham, MA) from 1998 to 2022: 17 510(k) clearances and 1 De Novo grant. Most are in product codes JXE (Device, Nerve Conduction Velocity Measurement) and GXY (Electrode, Cutaneous). Its devices cite 34 predicates, 22 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Neurometrix, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2008: 22009: 32012: 22013: 12014: 22016: 12022: 1
2007high 3 (2009) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Neurometrix, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Neurometrix, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report